Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Post-Transplant Events

Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?

Abstract

Bronchiolitis obliterans (BO) is a late non-infectious pulmonary complication after allogeneic hematopoietic SCT. Among 982 patients after myeloablative hematopoietic SCT between January 2000 and October 2010, 68 were diagnosed with BO according to NIH criteria. The median onset of BO was 18 months post transplant, 5-year cumulative incidence was 5.8% and 5-year mortality 41%. BO prevalence rate was 10% among all long-term surviving hematopoietic SCT recipients and 12% among chronic GVHD-patients. Chronic GVHD, peripheral SCT and ABO blood group incompatibility were identified as risk factors associated with BO. IgG levels were significantly decreased at the onset of BO (6.7 g/L±0.7, P=0.001), the mean exhaled NO concentrations were lower in BO-patients than in stem cell recipients without BO (14 p.p.b.±0.9 vs 20 p.p.b.±2.1) or healthy controls (25 p.p.b.±2.4, P<0.001). Hypoxia-inducible factor 1 alpha (HIF-1α) was significantly elevated in BO as compared with healthy controls or GVHD-patients without lung involvement (340±61 vs 127±22 vs 140±32, P=0.02). Calculated 5-year survival was superior in female than in male BO-patients (86 vs 45%, P=0.04). These results emphasize the relevance of BO as serious late complication with substantial mortality and point to essential pathophysiological changes due to regulatory responses to hypoxia.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Chan CK, Hyland RH, Hutcheon MA . Pulmonary complications following bone marrow transplantation. Clin Chest Med 1990; 11: 323–332.

    CAS  PubMed  Google Scholar 

  2. Yoshihara S, Yanik G, Cooke KR, Mineishi S . Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 749–759.

    Article  Google Scholar 

  3. Sakaida E, Nakaseko C, Harima A, Yokota A, Cho R, Saito Y et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003; 102: 4236–4242.

    Article  CAS  Google Scholar 

  4. Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998; 100: 680–687.

    Article  CAS  Google Scholar 

  5. Patriarca F, Skert C, Sperotto A, Damiani D, Cerno M, Geromin A et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 2004; 33: 751–758.

    Article  CAS  Google Scholar 

  6. Duncker C, Dohr D, Harsdorf S, Duyster J, Stefanic M, Martini C et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant 2000; 25: 1263–1268.

    Article  CAS  Google Scholar 

  7. Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.

    Article  CAS  Google Scholar 

  8. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  Google Scholar 

  9. Nakaseko C, Ozawa S, Sakaida E, Sakai M, Kanda Y, Oshima K et al. Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation. Int J Hematol 2011; 93: 375–382.

    Article  Google Scholar 

  10. Au BK, Au MA, Chien JW . Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1072–1078.

    Article  Google Scholar 

  11. Chien JW . Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation. Expert Rev Respir Med 2011; 5: 127–135.

    Article  Google Scholar 

  12. Spitale N, Popat N, McIvor A . Update on exhaled nitric oxide in pulmonary disease. Expert Rev Respir Med 2012; 6: 105–115.

    Article  CAS  Google Scholar 

  13. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810–3820.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Dales JP, Beaufils N, Silvy M, Picard C, Pauly V, Pradel V et al. Hypoxia inducible factor 1alpha gene (HIF-1alpha) splice variants: potential prognostic biomarkers in breast cancer. BMC Med 2010; 8: 44.

    Article  Google Scholar 

  15. Elmaagacli AH, Freist A, Hahn M, Opalka B, Seeber S, Schaefer UW et al. Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of bcr-abl fusion transcripts detected using a new real-time polymerase chain reaction method. Br J Haemtol 2001; 113: 1072–1075.

    Article  CAS  Google Scholar 

  16. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912–930.

    Article  Google Scholar 

  17. Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  18. Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695–706.

    Article  CAS  Google Scholar 

  19. Ditschkowski M, Elmaagacli AH, Trenschel R, Peceny R, Koldehoff M, Schulte C et al. T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica 2007; 92: 558–561.

    Article  Google Scholar 

  20. Santo Tomas LH, Loberiza FR, Klein JP, Layde PM, Lipchik RJ, Rizzo JD et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005; 128: 153–161.

    Article  Google Scholar 

  21. Auberger J, Clausen J, Kircher B, Kropshofer G, Lindner B, Nachbaur D . Allogeneic bone marrow vs peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients. Eur J Haematol 2011; 87: 531–538.

    Article  Google Scholar 

  22. Watkins TR, Chien JW, Crawford SW . Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant. Semin Respir Crit Care Med 2005; 26: 482–489.

    Article  Google Scholar 

  23. Stussi G, Mueller RJ, Passweg J, Schanz U, Rieben R, Seebach JD . ABO blood group incompatible haematopoietic stem cell transplantation and xenograft rejection. Swiss Med Wkly 2007; 137: 13–20.

    PubMed  Google Scholar 

  24. Kuzmina Z, Greinix HT, Weigl R, Körmöczi U, Rottal A, Frantal S et al. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia. Blood 2011; 117: 2265–2274.

    Article  CAS  Google Scholar 

  25. Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW . Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988; 72: 621–627.

    CAS  Google Scholar 

  26. Finke J, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR et al. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial. Biol Blood Marrow Transplant 2012; 18: 1716–1726.

    Article  Google Scholar 

  27. Tam A, Morrish D, Wadsworth S, Dorscheid D, Man SF, Sin DD . The role of female hormones on lung function in chronic lung diseases. BMC Womens Health 2011; 11: 24–33.

    Article  Google Scholar 

  28. Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60: 992–997.

    Article  CAS  Google Scholar 

  29. Vegeto E, Cuzzocrea S, Crisafulli C, Mazzon E, Sala A, Krust A et al. Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation. Endocrinology 2010; 151: 174–184.

    Article  CAS  Google Scholar 

  30. Mandhane PJ, Hanna SE, Inman MD, Duncan JM, Greene JM, Wang HY et al. Changes in exhaled nitric oxide related to estrogen and progesterone during the menstrual cycle. Chest 2009; 136: 1301–1307.

    Article  CAS  Google Scholar 

  31. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S . Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181: 852–857.

    Article  CAS  Google Scholar 

  32. Silkoff P . History, technical and regulatory aspects of exhaled nitric oxide. J Breath Res 2008; 2: 037001.

    Article  Google Scholar 

  33. Abba AA . Exhaled nitric oxide in diagnosis and management of respiratory diseases. Ann Thorac Med 2009; 4: 173–181.

    Article  Google Scholar 

  34. Neurohr C, Huppmann P, Leuschner S, von Wulffen W, Meis T, Leuchte H et al. Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2011; 11: 129–137.

    Article  CAS  Google Scholar 

  35. Vyas-Read S, Shaul PW, Yuhanna IS, Willis BC . Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 293: L212–L221.

    Article  CAS  Google Scholar 

  36. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355: 343–353.

    Article  CAS  Google Scholar 

  37. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2005; 288: L450–L459.

    Article  CAS  Google Scholar 

  38. Takenaka K, Nishimura Y, Nishiuma T, Sakashita A, Yamashita T, Kobayashi K et al. Ventilator-induced lung injury is reduced in transgenic mice that overexpress endothelial nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1078–L1086.

    Article  CAS  Google Scholar 

  39. Cattaneo MG, Cappellini E, Benfante R, Ragni M, Omodeo-Salè F, Nisoli E et al. Chronic deficiency of nitric oxide affects hypoxia inducible factor-1α (HIF-1α) stability and migration in human endothelial cells. PLoS One 2011; 6: e29680.

    Article  CAS  Google Scholar 

  40. Kenneth NS, Rocha S . Regulation of gene expression by hypoxia. Biochem J. 2008; 414: 19–29.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Ditschkowski.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ditschkowski, M., Elmaagacli, A., Koldehoff, M. et al. Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?. Bone Marrow Transplant 48, 1224–1229 (2013). https://doi.org/10.1038/bmt.2013.17

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.17

Keywords

This article is cited by

Search

Quick links